Acromegaly Market Report gives readers a thorough assessment of key market drivers, restraints, prospects, opportunities, restraints, current trends, and technological and industrial breakthroughs that will influence market growth. The detailed market research, industry sector growth and development, and new product introductions covered in this report on the Acromegaly Market are of great assistance to the important new commercial players joining the market.
This Acromegaly Market report research conducts a careful market evaluation and provides a professional analysis of the industry taking into account market development, present market circumstances, and forecasts for the future. The market driving factors, market overview, industry volume, and market share are also highlighted in this Acromegaly Market report analysis.
Regions Covered in the Report-
Click the link to get a Sample Copy of the Report before purchase: https://www.delveinsight.com/sample-request/acromegaly-market
Acromegaly: An Overview
Acromegaly is a hormonal disorder that results from the availability of excessive growth hormone (GH) in the body, which is produced by the pituitary gland (a small gland in the brain). In acromegaly, the pituitary produces an immoderate amount of GH, which is resulted from benign or noncancerous tumors on the pituitary. These benign tumors are called Adenomas.
Key highlights of the Acromegaly Market Report
Acromegaly Epidemiology Insights
Acromegaly is a very rare disorder caused, in most cases, by a tumor of the pituitary gland that produces too much growth hormone (GH). Nearly all pituitary tumors, including those that cause acromegaly, are benign, and not malignant. However, they can become quite large and expand beyond the normal confines of the pituitary gland.
Acromegaly Epidemiology Segmentation in the 7MM
Acromegaly Treatment Market
The current treatment method for Acromegaly is focused on preventing the tumor compression of surrounding tissues by excising the diseases causing areas, and on reducing GH and IGF-1 levels to normal. Although, the primary treatment method for Acromegaly is transsphenoidal surgery, although all the patients are not eligible for surgery. Patients diagnosed with microadenomas and those with macroadenomas not close to other key structures in the brain, such as the nerves supplying the eyes or nearby blood vessels, are recommended for surgery. The cure rate of surgery is about 80% for microadenomas and 40‒50% for macroadenomas.
Acromegaly Market Insights
As per the literature reviews by Lim et al., titled “The role of combination medical therapy in the treatment of acromegaly,” pegvisomant and SSA combination has demonstrated good biochemical control in the majority of patients, and may allow individual drug dosage reductions, but patients require close monitoring for liver enzyme elevations. The combination of cabergoline, to SSA is relatively well tolerated and most likely to be effective in patients with very mild IGF-1 elevations. It was also found that the combination of pegvisomant and cabergoline may be useful in a select group of patients with mild IGF-1 elevations, particularly in the setting of intolerance to SSA or when the cost of SSA-Peg therapy is prohibitive.
Acromegaly Emerging Therapies
The emerging therapies for the treatment of Acromegaly includes Octreotide capsules (Chiasma Pharma), Veldoreotide (Strongbridge Biopharma), CAM2029 (Camurus), CRN00808 (Crinetics Pharmaceuticals), IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), and MTD201 (Midatech). Octreotide capsules have been granted orphan designation in the US and the European Union for the potential treatment of Acromegaly.
Make an Enquiry Before Buying- https://www.delveinsight.com/sample-request/acromegaly-market
Table of Content
1. Key Insights
2. Executive Summary
3. Competitive Intelligence Analysis for Acromegaly
4. Acromegaly Market Overview at a Glance
5. Acromegaly Disease Background and Overview
6. Patient Journey
7. Acromegaly Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Acromegaly Unmet Needs
10. Key Endpoints of Acromegaly Treatment
11. Acromegaly Marketed Products
12. Acromegaly Emerging Therapies
13. Acromegaly Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Acromegaly Market Outlook
16. Access and Reimbursement Overview of Acromegaly
17. KOL Views
18. Acromegaly Market Drivers
19. Acromegaly Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Acromegaly Market Report Highlights
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/